Leadership and Strategy in Pharmaceuticals and Biotech
Revolutions in technology, markets, and government policy are transforming the playing field for pharmaceutical and biotechnology companies. This program prepares high-potential executives to become better managers and leaders—and lays a foundation for strategically positioning their companies for a world of change.
What You Can Expect
Created to enhance individual leadership capacity and boost corporate performance, this leadership development program enables participants to evaluate alternative business models, competitive strategies, and financial approaches, as well as explore issues ranging from profitability, organizational change, and intellectual property to global distribution.
Your Course of Study
Case studies, lectures, and panel sessions explore the industry's defining issues. The intensive curriculum examines areas such as R&D and product lifecycle management, which present formidable management challenges requiring expert leadership.
Who Is Right for the Program
The program is designed for senior executives and small teams responsible for process research and development, research and discovery, clinical development, regulatory affairs, product development, manufacturing, operations, marketing, business development, and finance.
| Fee: | $9,750 |
The program fee covers tuition, books, case materials, accommodations, and most meals.
Programs, dates, fees, and faculty are subject to change.
In accordance with Harvard University policy, Harvard Business School does not discriminate against any person on the basis of race, color, sex or sexual orientation, gender identity, religion, age, national or ethnic origin, political beliefs, veteran status, or disability in admission to, access to, treatment in, or employment in its programs and activities.